Copyright
©The Author(s) 2023.
World J Hepatol. Oct 27, 2023; 15(10): 1109-1126
Published online Oct 27, 2023. doi: 10.4254/wjh.v15.i10.1109
Published online Oct 27, 2023. doi: 10.4254/wjh.v15.i10.1109
Table 4 Risk factors for side effects of drug therapy in Wilson’s disease
Side effect of drugs | Risk factor | How to differentiate |
Neurological worsening with D-penicillamine or trientine | Pre-existing neurological Wilson disease | Exchangeable copper and relative exchangeable copper |
Cytopenia due to D-penicillamine | Co-existing hypersplenism due to portal hypertension | Bone marrow biopsy |
- Citation: Ghosh U, Sen Sarma M, Samanta A. Challenges and dilemmas in pediatric hepatic Wilson’s disease. World J Hepatol 2023; 15(10): 1109-1126
- URL: https://www.wjgnet.com/1948-5182/full/v15/i10/1109.htm
- DOI: https://dx.doi.org/10.4254/wjh.v15.i10.1109